Plan of Study

TMC Doctorate of Nursing Practice Degree Plan of Study

             
Summer I
 
Fall I
 
Spring I
 
Total
BIOL 5510 & 5510L
Gross Anatomy for Nurse Anesthetists w/lab
4 BMS5539
Mammalian Physiology
4 BIOL 5540
Pathophysiology
4  
N5615NA
Chemistry and Physics for the Nurse Anesthetist
2 PHARM5519
Pharmacology I
4 PHARM5520
Pharmacology II
5  
LSMBB 5510
Graduate Biochemistry for Nurse Anesthetists
1 N5612
Statistics I
3 N5555
Nursing Research
3  
N5601
Clinical Institute I
NC N5619NAO
Orientation to Nurse Anesthesia Practice
2 N5619NAB
Basic Principles of Nurse Anesthesia  Practice
2  
        N5650NAO
Clinical Anesthesia Orientation
   
TOTAL 7   13   14 34
             
Summer II
 
Fall II
 
Spring II
   
N5609
Clinical Institute II
1 N5607NA
Health Care Policy & Leadership in Nurse Anesthesia Practice
2 N5619NA3
Principles of Nurse Anesthesia Practice III
3  
N5627NA
Regional Anesthesia
1 N5628NA2
Advanced Physical Health Assessmt for the Nurse Anesthetist II
2 N5638NA1
Pharmacology of Anesthesia I
1  
N5628NA1 Advanced Physical Health Assessment for the Nurse Anesthetist I 1 N5619NA2  Principles of Nurse Anesthesia Practice II 3 N5640NA   Pediatric Anesthesia 1  
N5619NA1
Principles of Nurse Anesthesia Practice I
2 N5636NA
Obstetrical Anesthesia
1 N5641NA
Acute and Chronic Pain Management
1  
    N5637
Healthcare Outcomes and Epidemiology
2      
        N5674NA1
Scholarly Project in Nurse Anesthesia I
2  
N5650NA1
Clinical Anesthesia I
  N5650NA2
Clinical Anesthesia II
  N5650NA3
Clinical Anesthesia III
   
TOTAL 5   10   8 23
             
Summer III
 
Fall III
 
Spring III
   
N5659NA
Health Systems, Economics and Quality in Nurse Anesthesia Practice
2 N5661NA1
Anesthesia & Co-Existing  Diseases I
2 N5661NA2
Anesthesia and Co-Existing  Diseases II
1  
N5638NA2
Pharmacology of Anesthesia II
2 N5643NA
Professional Practice for the Nurse Anesthetist
2 N5674NA4
Scholarly Project in Nurse Anesthesia IV
2  
N5674NA2
Scholarly Project in Nurse Anesthesia II
  N5674NA3
Scholarly Project in Nurse Anesthesia III
2  N5642NA
Comprehensive Review
 1  
N5650NA4
Clinical Anesthesia IV
2 N5650NA5
Clinical Anesthesia V
  N5650NA6
Clinical Anesthesia VI
   
TOTAL 6   6   4 16
             
        Program Total Cr Hrs   73

Recent Posts

Sol Shnider Obstetric Anesthesia Meeting

I recently had the pleasure of attending the Sol Shnider Obstetric Anesthesia Meeting in San Francisco this March and learned a few new things, validated some of my current practices, and enhanced my interest in obstetric anesthesia.  Several of you may shudder at the thought of the OB floor, but I know there are just as many who share my enthusiasm for providing labor analgesia and anesthesia to our many parturients.

Preeclampsia (PE) was a hot topic given the release of the American Congress of Obstetricians and Gynecologists (ACOG)’s Task Force on Hypertension in Pregnancy in November 2013.  The report generated a substantial paradigm shift that contradicts much of what we previously accepted about the diagnosis of PE; proteinuria is no longer a requirement to definitively diagnosis pre-eclampsia with severe features.  The terms “mild preeclampsia” and “severe preeclampsia” are now “preeclampsia with/without severe features.”  These severe features are:

  • Hypertension: SBP ≥160 or diastolic ≥100 on two occasions at least four house apart while the patient is on bed rest (unless antihypertensive therapy is initiated before this time).
  • Thrombycytopenia (platelet count <100,000)
  • Impaired liver function (elevated blood levels of liver transaminases to twice the normal concentration), severe persistent RUQ or epigastric pain unresponsive to medication and not accounted for by alternative diagnoses, or both.
  • New development of renal insufficiency (elevated serum creatinine greater than 1.1 mg/dL, or doubling of serum creatinine in the absence of other renal disease).
  • Pulmonary edema.
  • New-onset cerebral or visual disturbances.

So what does this mean for anesthesia? There are two changes in the management of PE that may affect a patient’s anesthetic plan.  First, timing of delivery for PE without severe features is now 37 weeks.  Second, in the postpartum management of PE, nonsteroidal anti-inflammatory agents may contribute to increased blood pressure and should be replaced by other analgesics in women with hypertension that persists for more than one day postpartum.  There are a few other recommendations worthy of mentioning.  Cesarean delivery is not necessary with a diagnosis of PE, delivery plan should be based on the clinical picture as a whole.  Magnesium sulfate, if utilized for severe PE, should be maintained intraoperatively.  A neuraxial anesthetic for either labor analgesia or anesthesia is recommended if sufficient time allows.

Hopefully, this brief synopsis provides some food for thought and keeps us in the know when collaborating with our obstetric colleagues and providing a safe and timely anesthetic. To view the full guidelines, click here.

  1. School of Nurse Anesthesia Fall Anesthesia Conference – Registration Available Soon! Leave a reply
  2. Practicing Compassion Comments Off
  3. TMC CEO Meets with Junior SRNAs Comments Off
  4. UMKC School of Nursing and Health Studies 40+ Anniversary Kickoff Celebration Comments Off
  5. Missouri Association of Nurse Anesthetists Fall Meeting 2014 Comments Off
  6. CRNA Night at the Royals Comments Off
  7. Fall Anesthesia Conference 2014 Comments Off